Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Neuroendocrine liver metastases are clinically challenging and often non-resectable due to their frequent disseminated distribution. Radioembolisation with yttrium-90 labelled microspheres represents an emerging modality for NELM.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Clift A
Authors: Clift A, Frilling A, Braat A, Alsafi A, Wasan H,
Keywords: liver, metastases, radioembolization, yttrium, selective internal radiation therapy,
Introduction: Debulking surgery, TAE and TACE procedures are undertaken in patients with metastatic NETs. Reducing the physical burden of disease may prolong survival and can improve the quality of life of patients. However, there is only limited quality of life data available after surgery despite the fact that is has been used routinely for many years.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Sinclair A, Tanno L, Jarvis E, Ramsey E, Naheed S,
Keywords: Quality of Life, Debulking Surgery, TAE, TACE, Metastatic, NETs,
Introduction: Liver resection has emerged as an effective treatment for secondary liver neuroendocrine tumours. “Associated liver partition and portal vein ligation for staged hepatectomy” (ALPPS) allows resection of liver tumours in 2 steps.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Pizanias M
Authors: Pizanias M, Papamichail M, Kontis E, Prassas E, Ramage J,
Keywords: ALPPS, neuroendocrine, hepatectomy,
Introduction: The presence of CTCs confers adverse prognosis in metastatic NET pts with heterogenous treatment history. Post treatment CTC count correlates with disease progression and overall survival.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Meyer T
Authors: Meyer T, Higgs K, Hickling M, Houchard A,
Keywords: midgut neuroendocrine tumor, CTC, lanreotide,
Introduction: Most patients with neuroendocrine tumors present liver metastases at some point of the clinical course. Liver directed treatment, such as 90 Yttrium is a method of treatment used in patients with non-resectable liver lesions, which is effective in the control of symptoms and tumor growth.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: García Mónaco R
Authors: García Mónaco R, Peralta O, O'Connor J, Pesce V, Bestani C,
Keywords: 90Yttrium, radioembolization, neuroendocrine tumors ,